Evidence map›Paper›PMID 31882457›Full record

ReviewIn vivo (Athens, Greece)

Reasons to Reconsider Risk Associated With Power Morcellation of Uterine Fibroids.

Carsten Holzmann, Wolfgang Kuepker, Birgit Rommel, Burkhard Helmke, Joern Bullerdiek

Open access · diamondAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Carsten HolzmannInstitute of Medical Genetics, University Rostock Medical Center, Rostock, Germany.
Wolfgang KuepkerCenter for Minimal Invasive Gynecology, Endometriosis and Reproductive Medicine, Baden Baden-Buehl, Germany.
Birgit RommelHuman Genetics, University of Bremen, Bremen, Germany.
Burkhard Helmke *Institute of Pathology, Elbe Clinics, Stade Clinic, Stade, Germany.
Joern Bullerdiek *Institute of Medical Genetics, University Rostock Medical Center, Rostock, Germany bullerd@uni-bremen.de.
University of Bremen · DEElbe Kliniken Stade-Buxtehude · DEUniversity of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Our insights into the molecular pathogenesis of uterine smooth muscle tumors have improved significantly. Accordingly, in the present review, we advocate a more refined risk assessment for patients considering surgical removal of fibroids or hysterectomy, respectively, requiring morcellation. For this procedure, the risk estimates given for the iatrogenic spread of a previously unexpected malignancy considerably vary among different studies. Nearly all previous studies conducted retrospectively refer to the risk of a patient having an unexpected malignancy at the time of surgery. We feel that, more appropriately, risk should refer to the number of tumors because, as a rule, every single nodule arises independently and, thus, carries an independent risk of being malignant or not. Furthermore, whether so-called parasitic fibroids carry an underestimated risk of stepwise malignant transformation is discussed.

Indexed as

FemaleHumansLeiomyomaMorcellationRetrospective StudiesUterine NeoplasmsUterusnumber of fibroidsparasitic leiomyomaspower morcellationreviewrisk assessmentUterine smooth muscle tumors

Identifiers

PMID31882457
PMCPMC6984091
OpenAlexW2997113868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.